DalsnaFinanceIPOs › Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. IPO

Completed

Cullinan Therapeutics, Inc. completed its initial public offering on NASDAQ on January 8, 2021, pricing at $21.00 a share.

TickerCGEM
ExchangeNASDAQ
StatusCompleted
Listing dateJanuary 8, 2021
Offering price$21.00
Shares offered11,900,000
Total raised$250M

Company coverage

Cullinan Therapeutics, Inc. — quote, profile and latest news →

Other recent IPOs

IPO data is compiled from SEC filings. This page is general information, not investment advice.